• Explore /
  • Poster
  • / Phase I study of nivolumab (Nivo) + <em>nab</em>-paclitaxel (<em>nab</em>-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).

Phase I study of nivolumab (Nivo) + nab-paclitaxel (nab-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).

Abstract Poster

Authors

null

Zev A. Wainberg

University of California Los Angeles School of Medicine, Los Angeles, CA

Zev A. Wainberg , Howard S. Hochster , Edward Jae-Hoon Kim , Ben George , Aparna Kalyan , E. Gabriela Chiorean , David Michael Waterhouse , Martin Gutierrez , Aparna Raj Parikh , Rishi Jain , Daniel R. Carrizosa , Hatem Hussein Soliman , Rafia Bhore , Sibabrata Banerjee , Larry Lyons , Chrystal Ursula Louis , Teng Jin Ong , Peter J. O'Dwyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02309177

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 298)

DOI

10.1200/JCO.2019.37.4_suppl.298

Abstract #

298

Poster Bd #

F16

Abstract Disclosures

Similar Posters

First Author: Zev A. Wainberg

Poster

2016 Gastrointestinal Cancers Symposium

A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.

A phase I trial of cabozantinib (XL184) and gemcitabine in advanced pancreatic cancer.

First Author: David Bing Zhen

First Author: Andrew L. Coveler

First Author: Gang Jin